Overview

Study of U101 for Bladder Pain and/or Urgency

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether intravesical U101 (alkalinized lidocaine-heparin) treatment reduces the symptoms of pelvic pain and/or urgency of bladder origin.
Phase:
Phase 2
Details
Lead Sponsor:
Urigen
Treatments:
Calcium heparin
Heparin
Lidocaine